On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study
Bernd Holleczek(Krebsregister Saarland), Sabine Luttmann(Fondazione IRCCS Istituto Nazionale dei Tumori), Karri Seppä, Ladislav Dušek(Institute of Health Information and Statistics), Nadya Dimitrova(Istituto Superiore di Sanità), Margit Mägi(Universidad de Granada), Aurélien Belot, Guy Launoy(Inserm), Jean Faivre(Institut de Cancérologie de Lorraine), Mario Šekerija(London Cancer), Silvia Rossi(University of Parma), Gerda Engholm(National Board of Health and Welfare), Marc Maynadié(Universidad de Granada), Pamela Minicozzi(Fondazione IRCCS Istituto Nazionale dei Tumori), Pascale Grosclaude(Seoul National University Children's Hospital), Silvia Francisci(Fondazione IRCCS Istituto Nazionale dei Tumori), Florence Molinié, Hans H. Storm(Danish Cancer Society), Brigitte Trétarre(Pancreatic Cancer Action Network), K. Henau, Anne‐Sophie Woronoff, Alain Monnereau, Michel Robaszkiewicz(Universidad de Granada), Nadine Bossard(Istituto Superiore di Sanità), Véronique Bouvier(Inserm), Tiiu Aareleid(Fondazione IRCCS Istituto Nazionale dei Tumori), Hermann Brenner(Universidad de Granada), Marc Colonna(Universidad de Granada), Anne‐Marie Bouvier(Inserm), Z. Valerianova(Istituto Superiore di Sanità), Nora Eisemann(University of Lübeck), Nea Malila(Istituto Superiore di Sanità), Kaire Innos(National Institute for Health Development), Miroslav Zvolský(Institute of Health Information and Statistics), Willi Oberaigner, M. Meyer(Universidad de Granada), Anne‐Valérie Guizard, Domenic Agius(Heritage Malta), X. Troussard, B. Lapôtre‐Ledoux(Fondazione IRCCS Istituto Nazionale dei Tumori), Monika Hackl(Universidad de Granada), Roland Stabenow(Fondazione IRCCS Istituto Nazionale dei Tumori), P. Arveux(Istituto Superiore di Sanità), S. Bara(Fondazione IRCCS Istituto Nazionale dei Tumori), Michel Velten(Pancreatic Cancer Action Network), E. Van Eycken(Istituto Superiore di Sanità), Isabelle Baldi(Pancreatic Cancer Action Network), Claire Schvartz(Fondazione IRCCS Istituto Nazionale dei Tumori), N. Zielonke(Istituto Superiore di Sanità)
Cited by 123
Related Papers
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k